Rapid Detection of Hepatitis B Virus in Blood Plasma by a Specific and Sensitive Loop-Mediated Isothermal Amplification Assay

Background. Hepatitis B virus (HBV) is an important blood-borne pathogen that causes hepatic inflammation and can lead to liver cirrhosis and hepatocellular carcinoma. Conventional methods of HBV detection are time consuming and require highly trained personnel and elaborate equipment. This report describes the development of a rapid, simple, specific, and sensitive loop-mediated isothermal amplification assay (LAMP) for detection of HBV genotypes A, B, C, D, E, and F in blood samples.

Methods. HBV standard plasma panels and clinical donor plasma specimens were used for the development and validation of the LAMP assay. Amplification was performed at 60°C for 60 minutes using extracted DNA or heat-treated plasma specimens without DNA extraction. The assay was evaluated for its ability to detect various HBV genotypes and for its sensitivity, specificity, and time-point of detection.

Results. The LAMP assay detected HBV genotypes A–F and demonstrated a sensitivity of 10–100 IU per reaction of HBV DNA. The assay also detected 69 of 75 (92%) HBV-positive donor plasma specimens tested and demonstrated a specificity of 100%.

Conclusions. These results demonstrate that our HBV-LAMP assay is rapid, sensitive and specific, and capable of detecting the major HBV genotypes. This assay could be used in clinical point-of-care settings, mainly in endemic and resource-limited environments for HBV diagnostics, donor screening, epidemiological studies, and therapeutic monitoring of patients undergoing antiviral treatment. Continue reading…….

Founded in 2015, Shufflex Biomed is headquartered in Germantown, Maryland, about 30 miles from Washington, DC and also based in Lower Johnsonville in Monrovia, Liberia, West Africa.

Pathogens we target

Pathogens Con't

Technologies

Features

Dr. Dougbeh Chris Nyan, M.D.

Inventor, Multiplex Pathogen Diagnostic Test

  • Biomedical research scientist; specializes in infectious disease diagnostics
  • Medical Degree: Charité-Medical Faculty; Humboldt-University of Berlin, Germany
  • Scientist/Fellow: US National Institutes of Health (NIH)
  • Scientist/Fellow: Laboratory of Emerging Pathogens, FDA
  • Scientist: Naval Medical Research Center
  • Scientist: BioReliance, Inc.
  • Research Fellow: University of Pennsylvania School of Medicine
  • Senior Scientist: Nabi Biopharmaceuticals Corp.
  • Testified before the US Congress on September 17, 2014 on the Ebola outbreak
  • Director: Diaspora Ebola Task Force
  • Member: International Society for Infectious Diseases (ISID)
  • Member: The European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
  • Member: Data Safety Monitoring Board (DSMB), US-West African PREVAIL (Vaccine Trails)